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Introduction: Impact of gender on severe infections is in highly controversial discussion with natural survival
advantage of females described in animal studies but contradictory to those described human data. This study
aims to describe the impact of gender on outcome in mixed intensive care units (ICUs) with a special focus on
sepsis.
Methods: We performed a prospective, observational, clinical trial at Charité University Hospital in Berlin, Germany.
Over a period of 180 days, patients were screened, undergoing care in three mainly surgical ICUs. In total, 709
adults were included in the analysis, comprising the main population ([female] n = 309, [male] n = 400) including
327 as the sepsis subgroup ([female] n = 130, [male] n = 197).
Results: Basic characteristics differed between genders in terms of age, lifestyle factors, comorbidities, and SOFA-
score (Sequential Organ Failure Assessment). Quality and quantity of antibiotic therapy in means of antibiotic-free
days, daily antibiotic use, daily costs of antibiotics, time to antibiotics, and guideline adherence did not differ
between genders. ICU mortality was comparable in the main population ([female] 10.7% versus [male] 9.0%; P =
0.523), but differed significantly in sepsis patients with [female] 23.1% versus [male] 13.7% (P = 0.037). This was
confirmed in multivariate regression analysis with OR = 1.966 (95% CI, 1.045 to 3.701; P = 0.036) for females
compared with males.
Conclusions: No differences in patients’ outcome were noted related to gender aspects in mainly surgical ICUs.
However, for patients with sepsis, an increase of mortality is related to the female sex.
Introduction
The impact of gender on severe infections is in highly
controversial discussion. A natural survival advantage
for females [1] in data from animal experiments seems
to be contradictory to human clinical data on sepsis-
related mortality [2-5]. Eachempati et al. [5] demon-
strated female gender as an independent predictor of
increased mortality in patients with documented infec-
tion in a surgical intensive care unit (ICU). He empha-
sised that different genders may need different types of
therapy. Depending on the chosen subgroup, Combes
et al. [3] reported an increased risk for women to die of
nosocomial infections.
Different pathomechanisms were addressed to be
responsible for these findings, including sex-related gene
polymorphisms [2], effects of sex hormones [6], or dif-
ferent intensities of care, with males receiving more
invasive procedures [7,8].
One fundamental issue is to make study populations
matchable for research projects (for example, for evalua-
tion of new interventions and drugs), but as well to
assess the severity of diseases in mixed populations or
for benchmarking purposes. Classification systems like
PIRO (predisposition, insult/infection, response, organ
dysfunction) included gender with the intention of
improving the comparability of studies. But although
* Correspondence: claudia.spies@charite.de
† Contributed equally
1Department of Anaesthesiology and Intensive Care, Charité
Universitaetsmedizin Berlin, Campus Charité Mitte and Campus Virchow-
Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
Full list of author information is available at the end of the article
Nachtigall et al. Critical Care 2011, 15:R151
http://ccforum.com/content/15/3/R151
© 2011 Nachtigall et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License http://creativecommons.org/licenses/by/2.0, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.discussion is nearly a decade old, still no agreement is
found as to whether female or male gender is a predis-
posing factor [9]. Le Gall et al. [10] created an extended
version of the Simplified Acute Physiology Score-II
(SAPS-II), including gender, giving male patients a
higher score for predicting mortality [10]. The author
excluded burned and coronary and cardiac surgery
patients; the latter is a population in which women
probably do worse [3]. Interestingly, it seems to be
highly cohort related whether men or women are more
likely to survive. This study aims to describe the impact
of gender on outcome of patients on mixed ICUs with a
special focus on sepsis patients.
Materials and methods
Study design, location, and patients
This prospective, observational, clinical trial was per-
formed during two 90-day data-acquisition periods from
January to March 2006 and February to May 2007 at
the Charité University Hospital in Berlin, Germany (ter-
tiary medical care center with 3,200 beds). Three mixed
ICUs comprising 61 mainly surgical ICU beds under
anesthesiologic management were included.
Patients with ARDS (acute respiratory distress syn-
drome) or neurologic diagnoses as well as patients from
different surgical disciplines, including abdominal, gyne-
cologic, cardiac, and neurosurgery or after severe trau-
mata were screened for inclusion. Every consecutive
adult (≥18 years) patient with more than 36 hours of
ICU treatment admitted to one of the three ICUs was
included prospectively into the study. For the purpose
of focusing on anti-infective therapy, only patients with
at least one day of antibiotic treatment were included in
the analysis.
All patients meeting the criteria for sepsis for at least
1 day during the ICU stay were assigned to a sepsis sub-
group. This subgroup was examined independently for
primary and secondary study aims.
Data collection and measurement
Data were recorded in daily rounds from medical
records, hospital mainframe computer, and patient data-
management system (PDMS; Copra System, Sasbachwal-
den, Germany). Data were collected every day for the
preceding 24 hours.
Data on vital signs, laboratory findings, microbiologic
and radiologic diagnostics, anti-infective, vasopressor,
and steroid agents, ventilation, pulmonary gas exchange,
urine output, and fluid balance were taken from the
PDMS.
Information regarding alcohol, drug, or nicotine
abuse or immunosuppressive status was taken from
the patient’s data file. The latter was defined for
all patients receiving corticosteroids or other
immunosuppressive agents, having HIV or leukemia,
or after chemotherapy. TISS-28 (Therapeutic Interven-
tion Scoring System-28), SOFA (Sequential Organ Fail-
ure Assessment), and SAPS-II (Simplified Acute
Physiology Score-II) scoring systems are measured reg-
ularly in included ICUs as surrogate markers for dis-
ease severity. Infections were screened by using
modified definitions of the Centers for Disease Control
and Prevention [11] and the guidelines for the manage-
ment of adults with hospital-acquired, ventilator-asso-
ciated, and healthcare-associated pneumonia of the
American Thoracic Society [12]. Duration of ventila-
tion was defined as the period of mechanical ventila-
tion support during the ICU stay of the patient
(intubated or via tracheostomy). ICU stay was defined
as number of days a patient remained in the ICU dur-
ing one hospital stay, including readmissions from reg-
ular wards. Sepsis, severe sepsis, and septic shock are
defined according to the national and international
sepsis guidelines [13-15]. Patients required demonstra-
tion of at least two of four signs of systemic inflamma-
tory response syndrome (body temperature, < 36°C or
> 38°C; tachycardia, > 90 beats/min; tachypnea, > 20
per minute, or hypocapnia < 32 mm Hg; leukopenia,
< 4,000 per milliliter; or leukocytosis, > 12,000 per
milliliter or left shift) associated with an infection.
Outcome parameters
Primary outcome parameter was ICU mortality rate for
male and female patients. As secondary outcome mea-
sures, quality and quantity of diagnostic efforts and anti-
biotic therapy were analyzed. Later, evolution of disease
severity by using the TISS-28 (Therapeutic Intervention
Scoring System) was examined.
SOP (standard operating procedure) adherence was
recorded during data collection but was scored after-
ward by independent experts. Process of assessment of
SOP adherence for treatment and diagnostics was pre-
viously described in detail [16].
Time analysis was performed as analysis of sepsis
onset, based on the previously mentioned definition and
first antibiotic treatment after onset. Duration until anti-
biotic therapy was estimated between these two time
points. Quantity of antibiotics was measured as amount
of antibiotic agents per day; prices rely on hospital phar-
macy lists from December 2005.
Statistics and ethical review
All study results are expressed as median with 25% to
75% quartiles (25|75), arithmetic mean (mean) ± stan-
dard deviation (± STD), or proportions [%] as appropri-
ate, depending on the proof for normality. For statistical
analysis, Wilcoxon-Mann-Whitney tests, the Student t
tests and c
2 tests were performed as appropriate, with a
Nachtigall et al. Critical Care 2011, 15:R151
http://ccforum.com/content/15/3/R151
Page 2 of 12two-tailed P value of < 0.05 considered statistically
significant.
Evolution of disease-severity scoring system TISS-28
(Therapeutic Intervention Scoring System) over the clin-
ical course was evaluated by using multivariate nonpara-
metric longitudinal data analysis in a two-factorial
design (Brunner analysis). For this analysis, patients
were included with at least two sequential values, and
number of consecutive days for longitudinal analysis
was limited by the days, with at least 50% of the study
population providing consistent data. This procedure
was chosen a priori to reveal consistent conclusions for
the whole population and to reduce the possibility of a
selection bias. Finally, the longitudinal analysis com-
pared data of the first consecutive 8 days of the ICU
stay. Expected mortality and ratio of observed and
expected mortality rates are calculated based on the
reported initial SAPS II scoring for each subgroup, as
described by Le Gall et al. [10].
To compare the risk of mortality for both genders,
univariate logistic regression analysis was performed
separately incorporating different cofactors (age, alcohol
abuse, nicotine abuse, drug abuse, immunosuppressive
status, admission category, coexisting diagnoses, infec-
tion focus, severe sepsis, septic shock, bacteria detected
during ICU stay, and surrogate markers for quality of
care). For the purpose of affirming the significant effects
of gender on mortality, study results were analyzed by
using multivariate logistic regression methods. Based on
the results of univariate logistic regression analyses, fac-
tors with significant association with mortality were
incorporated into multivariate analysis. Multivariate
regression analyses also included stepwise backward
selection to reveal the most relevant associated para-
meters for mortality to validate the findings. Odds ratios
(ORs) with 95% confidence intervals (CIs) and the cor-
responding P values were calculated for each risk factor.
Quality of regression models was assessed with Hosmer-
Lemeshow tests for model calibration. All numeric cal-
culations were performed with PASW 18 (SPSS, Inc.,
Chicago, IL 60606, U.S.A.) and SAS version 9.1 (SAS
Institute Inc., 2003, Cary, IN, U.S.A.).
The local Ethics Review Board and the data safety autho-
rities approved this study. The Ethics review board waived
the need for patient informed consent to be obtained
because of the observational character of the study.
Results
Basic characteristics
Altogether, 986 patients were screened, and 709 with
antibiotic treatment were included in further analyses
(Figure 1). This main population included 309 women
and 400 men, with 130 women and 197 men with sepsis
comprising the sepsis subgroup for further analysis.
In the main population, basic characteristics differed
between genders in means of age, drug abuse, nicotine
abuse, alcohol abuse, vascular diseases, and median
SOFA Score on admission. Duration of mechanical ven-
tilation for patients with ventilation support was shorter
for women than for men, as displayed in Table 1. Other
parameters, like length of ICU stay, immunosuppressive
status, comorbidities, admission categories, surgical cate-
g o r y ,S A P S - I I ,a n dT I S S - 2 8o na d m i s s i o nd i dn o td i f f e r
between genders.
Subgroup analysis for sepsis patients showed differ-
ences of basic characteristics in age, drug abuse, alcohol
abuse, immunosuppressive status, vascular disease, and
median SOFA Score on admission, as summarized in
Table 1. Other parameters like duration of mechanical
ventilation, length of ICU stay, comorbidities, admission
categories, surgical category, SAPS-II, and TISS-28 on
admission did not differ between genders.
Diagnostic efforts, patterns of infections, and antibiotic
therapy
In the main population, microbiologic diagnostics in
relation to length of ICU stay (% LOS) did not differ,
but radiologic diagnostics was reduced for women
(Table 1). A higher percentage of men had an infection,
and pneumonia was less often seen in women, but con-
versely, lower urinary tract infections were more com-
mon in women (Table 2). Notably, quality of antibiotic
therapy in means of antibiotic-free days, daily antibiotic
use (DAU) in agents per day, daily costs of antibiotics,
and SOP adherence in percentage of all ICU days did
not differ between genders (Table 1).
Similarly, in the sepsis subgroup, radiologic diagnos-
tics was performed less often in women (Table 1). Dis-
tribution of urinary tract infections differed significantly
between males and females (Table 2). The remaining
parameters were equally distributed between groups
(Tables 1 and 2).
Time to antibiotic therapy
For the sepsis subgroup, no statistically significant dif-
ference appeared for the time to antibiotics. Duration
from onset of sepsis to antibiotic therapy in median was
♀ 0.54 h (25%|75% Quartiles 0.0|4.70 h) versus ♂ 1.5 h
(25%|75% quartiles, 0.0|6.25 h; P = 0.126).
Mortality
ICU mortality in the main study population was equal
between both genders (♀ 10.7% versus ♂ 9.0%; P =
0.523), but differed significantly in the sepsis subgroup
(♀ 23.1% versus ♂ 13.7%; P = 0.037), as displayed in
Figure 2.
T h eO / Em o r t a l i t yr a t ei nt he main population was
0.539 (95% CI, 0.378 to 0.747) for men and 0.699 (95%
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0.596 (95% CI, 0.393 to 0.869) for men and 0.935 (95%
CI, 0.629 to 1.332) for women, respectively [10].
In the female population, in 2.9%, therapy was discon-
tinued. In male patients, this proportion was nearly
equally contributed with 2.3% of patients, P = 0.634.
Logistic regression analysis
With univariate logistic regression, risk factors for mor-
tality were assessed (Table 3). For the main study, popu-
lation age, TISS-28 on admission, occurrence of
infection during ICU stay, pneumonia, and septic shock
were significantly associated with mortality. Alternatively
to TISS-28, severity of disease scoring system SAPS-II
also showed this association, with an OR of 1.066 (95%
CI, 1.048 to 1.085). Additionally, difficult-to-treat
pathogens and SOP adherence < 65% were also signifi-
cantly associated with mortality.
Based on these findings, a multivariate logistic regres-
sion model was performed to affirm the effect of gender
adjusted to other relevant factors for mortality. The
resulting odds ratio for the parameter gender was 1.277
for women compared with men but without reaching a
level of significance (Table 3).
The same methods were used to evaluate the sepsis sub-
group with gender, age, TISS-28 on admission, occurrence
of pneumonia, septic shock, and adherence to SOPs < 65%
significantly associated with ICU mortality (Table 4). The
resulting multivariate logistic regression model showed
gender as a significant factor for mortality in this popula-
tion, with an odds ratio of 1.909 for women compared
with men in the full model. A stepwise backward-selection
consecutively admitted patients 
N= 986
patients included for analysis
N= 709
Female patients 
N= 309
Male patients 
N= 400
excluded: patients without 
antibiotic therapy
N= 277
with sepsis
N= 130
with sepsis
N= 197
Figure 1 Flow chart for study enrollment and patient selection.
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Main population Sepsis population
♂♀♂♀
n = 400 n = 309 n = 197 n = 130
Age (years) 66 (51|72)
a 68 (54|78)
a 64 (50|72)
a 68 (57|78)
a
Drug abuse 18 (4.5%)
a 3 (1.0%)
a 14 (7.1)
a 1 (0.8)
a
Nicotine abuse 56 (14.0%)
a 15 (4.9%)
a 25 (12.7) 9 (6.9)
Alcohol abuse 55 (13.8%)
a 10 (3.2%)
a 33 (16.8)
a 8 (6.2)
a
Preexisting comorbidity
Immunosuppressive status 27 (6.8%) 31 (10.0%) 11 (5.6%)
a 18 (13.8%)
a
Vascular disease 202 (50.5%)
a 111 (35.9%)
a 100 (50.8%)
a 45 (34.6%)
a
Hypertension 178 (44.5%) 147 (47.6%) 82 (41.6%) 60 (46.2%)
Chronic liver disease 32 (8.0%) 16 (5.2%) 17 (8.6%) 8 (6.2%)
Chronic renal disease 67 (16.8%) 46 (14.9%) 37 (18.8%) 24 (18.5%)
Metabolic disease 172 (43.0%) 141 (45.6%) 102 (51.8%) 71 (54.6%)
Chronic lung disease 45 (11.3%) 37 (12.0%) 27 (13.7%) 20 (15.4%)
Psychiatric disease 81 (20.3%) 47 (15.2%) 53 (26.9%) 31 (23.8%)
Admission category
Infection 14 (3.5%) 10 (3.2%) 10 (5.1%) 7 (5.4%)
Malignant tumor 65 (16.3%) 80 (25.9%) 27 (13.7%) 21 (16.2%)
Neurology 43 (10.8%) 34 (11.0%) 23 (11.7%) 20 (15.4%)
Cardiovascular 154 (38.5%) 90 (29.1%) 67 (34.0%) 34 (26.2%)
Respiratory 21 (5.3%) 17 (5.5%) 15 (7.6%) 16 (12.3%)
Gastrointestinal 30 (7.5%) 19 (6.1%) 20 (10.2%) 9 (6.9%)
Trauma 42 (10.5%) 29 (9.4%) 23 (11.7%) 11 (8.5%)
Others 31 (7.8%) 30 (9.7%) 12 (6.1%) 12 (9.2%)
Surgical patients 327 (81.8%) 262 (84.8%) 151 (76.6%) 100 (76.9%)
OP category of surgical patients
Neurosurgical 38 (11.6%) 40 (15.3%) 19 (12.6%) 19 (19.0%)
Musculoskeletal 59 (18.0%) 46 (17.6%) 33 (21.9%) 19 (19.0%)
Cardiac 134 (41.0%) 65 (24.8%) 52 (34.4%) 20 (20.0%)
Abdomen and urogenital 83 (25.4%) 97 (37.0%) 41 (27.2%) 30 (30.0%)
Thorax 9 (2.8%) 9 (3.4%) 4 (2.6%) 7 (7.0%)
Soft tissue and others 4 (1.2%) 5 (1.9%) 2 (1.3%) 5 (5.0%)
Severity of disease scorings
SAPS-II on admission 35 (26|47) 34 (26|45) 39 (28|51) 40 (29|53)
SOFA on admission 5 (2|8)
a 4 (2|7)
a 6 (4|9)
a 5 (3|7)
a
TISS-28 on admission 35 (26|42) 33 (27|40) 37 (29|44) 35 (28|41)
Diagnostic patterns
Microbiologic diagnostics (% of LOS) 17.0 (± 20.4) 14.9 (± 19.8) 27.6 (± 19.3) 24.3 (± 17.3)
Radiologic diagnostics of (% of LOS) 55.2 (± 30.0)
a 51.1 (± 31.0)
a 52.1 (± 23.0)
a 45.4 (± 21.3)
a
Antibiotic therapy
SOP adherence (% of LOS) 77.3 (± 32.6) 79.0 (± 33.2) 68.9 (± 34.4) 69.3 (± 36.4)
DAU in agents per day 1.0 (0.5|1.5) 1.0 (0.5|1.5) 1.26 (± 0.65) 1.18 (± 0.74)
Antibiotic-free days (% of LOS) 28.8 (± 27.9) 27.3 (± 27.6) 22.0 (± 22.4) 25.4 (± 24.3)
Daily costs for antibiotics in € 19.3 (± 25.5) 15.6 (± 21.6) 30.7 (± 28.6) 26.7 (± 27.1)
Duration of treatment
ICU stay in days 4 (2|11) 4 (2|9.5) 10 (5|19) 10 (5|20)
Invasive ventilation in hours
b 27 (11|121)
a 20 (8|95)
a 96 (22|305) 85 (16|300)
aP < 0.05 in two-tailed significance tests.
bVentilated patients in main population, n = ♂ 331, ♀ 226; in sepsis subgroup, n = ♂ 182, ♀ 115. Binary parameters
given in total and percentage (%), continuous variables presented in median and 25% and 75% quartiles (25%|75%) or mean (± STD). DAU, daily antibiotic use;
LOS, length of stay; OP, operation; SAPS, simplified acute physiology score-II; SOFA, sequential organ-failure assessment; SOP, standard operating procedure; TISS-
28, therapeutic intervention scoring system-28.
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with four variables (gender, age, TISS-28 on admission,
and septic shock), with an OR for mortality of 1.966 for
women compared with men (Table 5).
Analysis of the progressive course of scoring system TISS-
28
Evolution of TISS-28 scoring for severity of disease for
men and women was compared via Brunner analysis over
the first eight consecutive ICU days. Differences between
groups were statistically significant in the nonparametric
multivariate analysis for longitudinal data for the first
independent factor, Gender (P < 0.001), and for interac-
tion between Gender and Time (P = 0.029) but not for the
second dependent factor, Time (P = 0.063). In the sepsis
subgroup, differences between groups were statistically
significant for Gender (P = 0.018) but not for Time (P =
0.257) and for the interaction between Gender and Time
(P = 0.662). These findings are also reflected in Figure 3,
illustrating the different development of TISS-28 over
time for women and men despite initially similar levels.
Discussion
Most important, we were able to demonstrate that a
gender-related effect on mortality is limited to the
specific subgroup of sepsis patients. Further, we showed
that despite smaller differences in the care process, qual-
ity and quantity of key interventions in infection man-
agement are distributed equally between genders. These
findings contribute to the discussion of whether differ-
ent levels of care have an impact on gender-related out-
come [8,17,18].
Concerning distribution of basic characteristics, we
were able to reproduce well-described differences
between genders comparing lifestyle risks, comorbidities,
and age [3,8]. Similarly, subgroup analysis for sepsis
patients showed differences in basic characteristics for
age, lifestyle risks, immunosuppressive status, and vascu-
lar disease. Women had lower SOFA score on admission
in the main study population as well as in the sepsis
subgroup. This finding is well described for other study
populations [19]. However, primary assessed scores
reflect only the moment of admission but not the
kinetic of clinical course, for which SOFA is not vali-
dated [20]. Because this scoring system does not take
gender into account [21,22], the gender-related differ-
ence in mortality is not reflected well and remains a
topic that must be elucidated.
Quantity of microbiologic diagnostics did not differ
between genders, but in men, more radiologic diagnostics
Table 2 Distribution of infections, infection characteristics, and pathogens for main and sepsis population
Main population Sepsis population
♂♀♂ ♀
Number 400 309 197 130
Patients with infections n (%) 248 (62.0%)
a 164 (53.1%)
a 197 (100%) 130 (100%)
Colitis, pseudomembranous 2 (0.5%) 3 (1.0%) 2 (1.0%) 2 (1.5%)
Pneumonia 135 (33.8%)
a 75 (24.3%)
a 124 (62.9%) 70 (53.8%)
Lower urinary tract infections 13 (3.3%)
a 34 (11.0%)
a 11 (5.6%)
a 30 (23.1%)
a
Bones and joints 11 (2.8%) 7 (2.3%) 8 (4.1%) 6 (4.6%)
Endocarditis 11 (2.8%) 7 (2.3%) 10 (5.1%) 6 (4.6%)
Abdomen 40 (10.0%) 28 (9.1%) 32 (16.2%) 18 (13.8%)
Soft tissue and wounds 80 (20.0%) 47 (15.2%) 55 (27.9%) 38 (29.2%)
Upper urinary tract infections 6 (1.5%) 4 (1.3%) 3 (1.5%) 1 (0.8%)
Meningitis 5 (1.3%) 5 (1.6%) 4 (2.0%) 3 (2.3%)
Bloodstream infection 35 (8.8%) 17 (5.5)%) 34 (17.3%) 16 (12.3%)
Fever of unknown origin 33 (8.3%) 24 (7.8%) 22 (11.2%) 17 (13.1%)
Catheter-related infections 17 (4.3%) 5 (1.6%) 17 (8.6%) 5 (3.8%)
SIRS occurrence n (%) 364 (91.0%) 290 (93.9%) 197 (100%) 130 (100%)
Sepsis occurrence n (%) 197 (49.3%) 130 (42.1%) 197 (100%) 130 (100%)
Severe sepsis occurrence n (%) 89 (22.3%)
a 48 (15.5%)
a 89 (45.2%) 48 (36.9%)
Septic shock occurrence n (%) 74 (18,5%) 41 (13,3%) 74 (37.6%) 41 (31.5%)
Fungi detected 64 (16.0%) 47 (15.2%) 61 (31.0%) 42 (32.3%)
Gram-negative germs detected 98 (24.5%) 58 (18.8%) 89 (45.2%) 52 (40.0%)
Difficult-to-treat bacteria detected 41 (10.3%) 28 (9.1%) 37 (18.8%) 26 (20.0%)
aP < 0.05 in a two-tailed c
2 test. More than one infection period per patient was possible. Difficult-to-treat pathogens include bacteria associated with potential
intrinsic or acquired resistance (methicillin-resistant Staphylococcus aureus, germs producing extended spectrum betalactamases, Vancomycin-resistant
Enterococci, nonfermenters like Pseudomonas spp., Stenotrophomonas maltophilia, Acinetobacter baumanii, Citrobacter spp., Enterobacter cloacae, Enterococcus
faecium, and Bacillus cereus). Binary parameters presented in total and percentage (%). SIRS, systemic inflammatory response syndrome.
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Valentin et al. [8], that men are more likely to obtain a
higher intensity of care in ICU. Furthermore in our
study, no differences were found for antibiotic-free days,
daily antibiotic use, daily costs of antibiotics, and SOP
adherence in percentage of all days–neither in the main
study population nor in the sepsis subgroup–showing
that in our study population, men and women get the
same quality and quantity of care in means of antibiotic
therapy. As time to antibiotics was found to be relevant
for ICU mortality, we also included this parameter in our
analysis but did not find significant differences between
genders [23].
In women, pneumonia as well as overall infection rate
was lower, but urinary tract infections occurred more
often. This goes along well with previously described
data [3,4,24,25]. A higher infection rate in men, mainly
based on increased pneumonia rates, may impair survi-
val. Conversely, in our main population, outcome of
gender was equal, but in the sepsis subgroup, women
w e r em o r el i k e l yt od i et h a nw e r em e n .A sw et h i n k
that gender differences are a matter of subgroup selec-
tion, this finding is in concordance with other published
studies in mixed ICUs, where several differences for
gender, but not for mortality, are described [3]. Experi-
mental data show a natural survival advantage after
polymicrobial sepsis for women [1], but human studies
focusing the impact of gender on sepsis-related mortal-
i t yg a v ei n c o n s i s t e n tr e s u l t s ,s h o w i n gal o w e r[ 7 , 1 9 ] ,
equal [26,27] or higher [5,28-30] mortality rate. Vincent
et al. [29] reported, in their European multicenter
cohort, higher mortality for women with sepsis than for
men [29]. Combes et al. [3], studying ICU patients with
sepsis, reported that female gender predicted mortality,
although in the univariate analysis, mortality was not
significantly different. Seymour et al. [28] reported a
higher mortality rate for women with Fournier gangrene,
with more male patients surviving the septic phase. In
contrast to this, Adrie et al. [29] found a survival advan-
tage in women older than 50 years, which is also
opposed to our findings [19]. In that study, Adrie et al.
postulated women older than 50 years to be postmeno-
pausal without measuring hormone status, which seems
to be of high importance. Further on, they included only
community-acquired sepsis and predominantly medical
patients, which is a difference from our and other study
populations. The results of the O/E mortality rate sug-
gest that the SAPS-II score provides the most reliable
ICU - Mortality
9,0%
10,7%
13,7%
23,1%
0%
5%
10%
15%
20%
25%
30%
35%
Main population                                                                        Sepsis subgroup
males females
p=0.523 p=0.037
n = 400                         n= 309
Main population
n = 197                         n= 130
Sepsis subgroup
Figure 2 ICU mortality for main study population and sepsis subgroup.
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Univariate logistic analysis Multivariate logistic analysis
Parameter OR (95% CI) P OR (95% CI) P
Gender ♀ vs. ♂ 1.209 (0.735-1.988) 0.455 1.277 (0.720-2.264) 0.403
Age 1.035 (1.015-1.055) < 0.001 1.041 (1.018-1.064) < 0.001
Alcohol abuse 1.341 (0.611-2.943) 0.464
Nicotine abuse 0.526 (0.186-1.490) 0.227
Drug abuse 0.976 (0.222-4.280) 0.974
Immune suppression 0.668 (0.234-1.904) 0.450
TISS-28 first 1.080 (1.053-1.108) < 0.001 1.066 (1.035-1.097) < 0.001
Infection during ICU stay 3.881 (1.745-8.633) 0.001 1.269 (0.487-3.304) 0.626
Infection type
Pneumonia 4.370 (2.613-7.311) < 0.001 1.377 (0.676-2.802) 0.378
Urinary tract infection 1.694 (0.728-3.941) 0.221
Abdomen 1.477 (0.698-3.127) 0.308
Bones and joints 1.164 (0.262-5.173) 0.842
Endocarditis 1.164 (0.262-5.173) 0.842
Meningitis 1.031 (0.129-8.262) 0.977
Wounds/soft issue 1.310 (0.713-2.404) 0.384
BSI 2.338 (0.258-21.220) 0.450
Colitis, pseudomembranous 2.338 (0.258-21.220) 0.450
Infection of unknown origin 0.883 (0.341-2.292) 0.799
Severe sepsis
a 4.110 (2.448-6.900) < 0.001
Septic shock 5.023 (2.963-8.515) < 0.001 2.746 (1.328-5.680) 0.006
ICU diagnoses
Infection 2.553 (0.922-7.068) 0.071
Neoplastic 0.556 (0.269-1.149) 0.113
Neurologic 0.348 (0.107-1.134) 0.08
Cardiovascular 1.170 (0.700-1.956) 0.548
Respiratory 4.306 (2.032-9.125) < 0.001 1.447 (0.542-3.860) 0.461
Gastrointestinal 1.322 (0.542-3.229) 0.540
Trauma 0.526 (0.186-1.490) 0.227
Miscellaneous 0.815 (0.315-2.108) 0.673
Postoperative admission 0.865 (0.457-1.637) 0.655
Type of surgery
Head 0.905 (0.399-2.053) 0.811
Musculoskeletal 0.972 (0.481-1.967) 0.938
Cardiac 1.136 (0.661-1.951) 0.645
Abdomen/urogenital 0.658 (0.351-1.233) 0.191
Thorax 1.164 (0.262-5.173) 0.842
Soft tissues and peripheral vascular 4.803 (1.174-19.651) 0.029 3.509 (0.613-20.073) 0.158
Fungi detected 4.255 (2.492-7.266) < 0.001 1.398 (0.701-2.788) 0.341
Gram-negative bacteria detected 2.929 (1.748-4.906) < 0.001 1.234 (0.605-2.513) 0.563
Difficult-to-treat pathogens detected
b 2.421 (1.248-4.697) 0.009 1.115 (0.499-2.493) 0.791
SOP adherence ≤65% 1.705 (1.011-2.874) 0.045 2.309 (1.182-4.511) 0.014
Effects of different factors on outcome in a mixed ICU population for study population (N = 709) by using univariate logistic regression analyses. Parameters
found to be relevant on a P < 0.05 level for ICU mortality entered multivariate logistic regression analysis. Quality of regression model tested with the Hosmer-
Lemeshow test, indicating good calibration (c
2 = 4.672; P = 0.792). BSI, bloodstream infection; SOP, standard operating procedure; TISS-28, therapeutic
intervention scoring system-28.
aSeptic shock entered multivariate analysis due to correlation;
bDifficult-to-treat pathogens include bacteria associated with potential intrinsic or acquired
resistance (methicillin-resistant Staphylococcus aureus, germs producing extended spectrum betalactamases, vancomycin-resistant Enterococci, nonfermenters like
Pseudomonas spp., Stenotrophomonas maltophilia, Acinetobacter baumanii, Citrobacter spp., Enterobacter cloacae, Enterococcus faecium, and Bacillus cereus).
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Page 8 of 12Table 4 Effects of different factors on outcome for sepsis subgroup (n = 327) by using univariate logistic regression
analyses
Univariate logistic analysis Multivariate logistic analysis
Parameter OR (95% CI) P OR (95% CI) P
Gender ♀ vs. ♂ 1.889 (1.062-3.359) 0.030 1.909 (1.002-3.638) 0.049
Age 1.036 (1.014-1.059) 0.001 1.037 (1.013-1.063) 0.003
Alcohol abuse 0.972 (0.408-2.317) 0.948
Nicotine abuse 0.428 (0.126-1.453) 0.174
Drug abuse 0.719 (0.158-3.277) 0.670
Immune suppression 0.740 (0.247-2.214) 0.590
TISS-28 first 1.063 (1.033-1.093) < 0.001 1.062 (1.028-1.098) < 0.001
Infection type
Pneumonia 1.960 (1.048-3.664) 0.035 1.120 (0.539-2.324) 0.762
Urinary tract infection 0.790 (0.316-1.977) 0.614
Abdomen 1.047 (0.477-2.298) 0.908
Bones and joints 0.782 (0.170-3.593) 0.752
Endocarditis 0.665 (0.147-3.010) 0.596
Meningitis 0.786 (0.093-6.655) 0.825
Wounds/Soft issue 0.787 (0.408-1.519) 0.476
BSI 1.589 (0.162-15.560) 0.691
Colitis, pseudomembranous 1.589 (0.162-15.560) 0.691
Infection of unknown origin 0.667 (0.249-1.788) 0.421
Severe sepsis
a 1.845 (1.037-3.280) 0.037
Septic shock 2.418 (1.354-4.319) 0.003 1.649 (0.854-3.184) 0.136
ICU diagnoses
Infection 1.492 (0.468-4.755) 0.499
Neoplastic 0.939 (0.414-2.130) 0.880
Neurologic 0.319 (0.095-1.071) 0.065
Cardiovascular 1.146 (0.624-2.107) 0.660
Respiratory 2.523 (1.117-5.699) 0.026 1.374 (0.521-3.620) 0.520
Gastrointestinal 1.263 (0.490-3.259) 0.629
Trauma 0.428 (0.126-1.453) 0.174
Miscellaneous 0.943 (0.310-2.873) 0.918
Postoperative admission 1.165 (0.581-2.336) 0.667
Type of surgery
Head 1.079 (0.450-2.589) 0.864
Musculoskeletal 0.573 (0.232-1.414) 0.227
Cardiac 1.335 (0.691-2.577) 0.390
Abdomen/Urogenital 0.954 (0.474-1.919) 0.894
Thorax 1.055 (0.222-5.016) 0.947
Soft tissues and peripheral vascular 3.694 (0.804-16.981) 0.093
Fungi detected 2.297 (1.282-4.118) 0.005 1.523 (0.782-2.968) 0.216
Gram-negative bacteria detected 1.341 (0.756-2.379) 0.315
Difficult-to-treat pathogens detected
b 1.300 (0.652-2.594) 0.457
SOP adherence ≤65% 1.139 (0.632-2.052) 0.664
Parameters found to be relevant on a P < 0.05 level for ICU mortality entered multivariate logistic regression analysis. Quality of regression model tested with
Hosmer-Lemeshow test indicating good calibration (c
2 = 7.014; P = 0.535). BSI, blood stream infection; SOP, standard operating procedure.
aSeptic shock entered multivariate analysis due to correlation;
bDifficult-to-treat pathogens include bacteria associated with potential intrinsic or acquired
resistance (methicillin-resistant Staphylococcus aureus, germs producing extended spectrum betalactamases, vancomycin-resistant Enterococci, Nonfermenters like
Pseudomonas spp., Stenotrophomonas maltophilia, Acinetobacter baumanii, Citrobacter spp., Enterobacter cloacae, Enterococcus faecium, and Bacillus cereus).
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Page 9 of 12predictive values for the subgroup of women with sepsis.
It is an interesting finding that might indicate a limita-
tion of intensive care scoring systems.
In our study, we also analyzed evolution of TISS-28
scoring for men and women. We found consistent dif-
ferences between genders being statistically significant.
As TISS-28 is a surrogate parameter for intensity of
care, our results coincide with the findings that men
r e c e i v em o r ei n v a s i v ep r o c e d u r e st h a nd ow o m e n ,
regardless of the reason of admission or procedures
[7,8]. Conversely, TISS-28 was thought to be used to
compare predicted survival in different populations
[21,22]. Based on these findings, it might be difficult to
use scoring systems not incorporating gender as an
independent factor for ICU mortality.
Limitations
Our study has several limitations. First, data were col-
lected in one tertiary care center but with three ICUs
with a very mixed population.
Second, we did not measure sex-hormone levels and
did not stratify for age, because postmenopausal status
is difficult to assess without measuring sex hormones.
As experimental data showed an influence of sex hor-
mones on outcome, this might alter our results. These
data advocate further prospective trials with specific
focus on this issue.
Third, we did not take into account marital status,
which is meant to have an influence on mortality from
sepsis [28]. Although having probably the same impact
on both genders, the fact that data were collected only
during winter and spring could theoretically represent
another limitation.
Fourth, 81.8% of our patients are surgical, so results
for medical patients might be different.
Finally, studies of gender-related differences are lim-
ited to nonrandomized designs. As in studies of other
not-modifiable factors like hospital admission time,
Table 5 Multivariate logistic regression analysis in a
stepwise backward model
Multivariate logistic analysis
Parameter OR (95% CI) P
Gender ♀ vs. ♂ 1.966 (1.045-3.701) 0.036
Age 1.038 (1.013-1.063) 0.002
TISS-28 first 1.069 (1.036-1.103) < 0.001
Septic shock 1.831 (0.977-3.432) 0.059
Multivariate logistic regression analysis in a stepwise backward model
confirming associations with mortality shown in Table 4: Hosmer-Lemeshow
test for the last step indicating good calibration (c
2 = 7.402; P = 0.494). TISS-
28, therapeutic intervention scoring system-28.
AB
Figure 3 TISS-28 scoring for severity of disease comparing gender over the first 8 consecutive ICU days. Error bars illustrate the
evolution of TISS-28 (Therapeutic Intervention Scoring System-28) scoring for severity of disease comparing gender (m, men; w, women) over
the first 8 consecutive ICU days. STD, standard deviation. (a) In the main population, differences between groups were statistically significant for
Gender (P < 0.001) and for interaction between Gender and Time (P = 0.029), but not for Time (P = 0.063). (b) In the sepsis subgroup,
differences between groups were statistically significant for Gender (P = 0.018) but not for interaction between Gender and Time (P = 0.662) or
Time (P = 0.257).
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Page 10 of 12ethnicity, or genotype we cannot rule out the possibility
of further confounders or interactions that were not
addressable in our careful multivariate evaluation [31].
Conclusions
In our population, it seems as if only in a sepsis sub-
group gender makes a difference and that if women
develop sepsis, they do worse than men. Thus, as sepsis
occurred more frequently in male patients, prevention
measures for infections might be more important for
men, but we should pay more attention to specific
therapies for women, because of their higher attributable
mortality if seriously infected.
Key messages
￿ Gender-related effect on mortality is limited to the
specific subgroup of sepsis patients.
￿ Quality and quantity of key interventions in infec-
tion management are distributed equally between
genders.
￿ ICU scoring systems should take gender into
account as an independent factor for mortality.
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